Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
In one of biotech’s hottest areas and with big partners like…
Immuno-oncology
CytoDyn Announces Execution of Exclusive Agreement with American Regent for Distribution…
Commercial
Rexgenero Appoints Dr Gilbert Wagener as Senior Vice President and Chief…
Commercial
Abivax treats first patient in Phase 2b/3 ABX464 Covid-19 clinical trial
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
UK mulls joining EU coronavirus vaccines strategy – FirstWord Pharma
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
In one of biotech’s hottest areas and with big partners like…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Clinical
Gilead’s Veklury gains conditional EU approval for treatment of COVID-19 –…
Immuno-oncology
The European Commission has Granted Orphan Medicinal Product Designation in the…
Clinical
Hydroxychloroquine found to significantly cut death rates in new COVID-19 study…
Immuno-oncology
Discovery of new step in how brain cells work could lead…
Home
Therapy areas
Immuno-oncology
Immuno-oncology
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Immuno-oncology
The European Commission has Granted Orphan Medicinal Product Designation in the EU for MIV-818 – FirstWord Pharma
Firstwordpharma News
-
July 4, 2020
Immuno-oncology
Discovery of new step in how brain cells work could lead to new therapies for epilepsy – FirstWord Pharma
Immuno-oncology
CytoDyn Announces Execution of Exclusive Agreement with American Regent for Distribution and Supply of Leronlimab for Treatment of COVID-19 in United States – FirstWord...
Immuno-oncology
Calithera Biosciences Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) – July 02, 2020
Immuno-oncology
Bolt Biotherapeutics Pushes Forward with Initiatives Following $93.5 Million Series C
Immuno-oncology
Biopharma Update on the Novel Coronavirus: June 29
Biospace News
-
June 29, 2020
0
Immuno-oncology
ERC Belgium Submits Marketing Authorization Application to European Medicines Agency (EMA)...
Biospace News
-
June 26, 2020
0
Immuno-oncology
Roche improves speed and accuracy of non-small cell lung cancer diagnosis...
Globenewswire News
-
June 26, 2020
0
Immuno-oncology
BioSpace Movers & Shakers, June 26
Biospace News
-
June 26, 2020
0
Immuno-oncology
Fennec Pharmaceuticals Announces Amendment to Increase Existing Senior Debt Facility
Biospace News
-
June 26, 2020
0
1
2
3
...
62
Page 1 of 62
- Advertisement -
MOST POPULAR
Regeneron Announces Upcoming Investor Conference Call – March 8, 2019
March 8, 2019
Ophthotech Reports Fourth Quarter and Full Year 2018 Financial and Operating...
February 26, 2019
Taro Provides Results for the Year Ended March 31, 2019
May 22, 2019
AbbVie and Jacobio Announce Strategic Collaboration to Advance SHP2 Inhibitors
June 1, 2020
Load more
HOT NEWS
Respiratory
Correct antibiotic dosing could preserve lung microbial diversity in cystic fibrosis
Commercial
BioSpace’s Global Biopharma Roundup: April 25
Commercial
VBI Vaccines Announces Late-Breaking Poster Presentation at EASL 2019
Phase III
Zydus announces second Phase 3 trial of Desidustat
